| Year |
Title |
Altmetric |
| 2023
|
Personalizing Direct Oral Anticoagulant Therapy for a Diverse Population: Role of Race, Kidney Function, Drug Interactions, and Pharmacogenetics.
Clinical Pharmacology and Therapeutics.
113:585-599.
2023
|
|
| 2023
|
The Projected Impact of Population-Wide Achievement of LDL Cholesterol <70 mg/dL on the Number of Recurrent Events Among US Adults with ASCVD.
Cardiovascular Drugs and Therapy.
37:107-116.
2023
|
|
| 2022
|
Lipid-Lowering Therapy Use and Intensification among United States Veterans Following Myocardial Infarction or Coronary Revascularization between 2015 and 2019.
Circulation: Cardiovascular Quality and Outcomes.
15:E008861.
2022
|
|
| 2022
|
Establishing Care Post Discharge Following a Heart Failure Hospitalization in an Uninsured Heart Failure Population.
American Journal of Cardiology.
179:46-50.
2022
|
|
| 2022
|
Lipoprotein(a) and the Risk for Coronary Heart Disease and Ischemic Stroke Events Among Black and White Adults With Cardiovascular Disease.
Journal of the American Heart Association.
11.
2022
|
|
| 2022
|
Factors associated with time to initiation of a PCSK9 inhibitor after hospital discharge for acute myocardial infarction.
Journal of Clinical Lipidology.
16:75-82.
2022
|
|
| 2022
|
Social Determinants of Health and 30-Day Readmissions among Adults Hospitalized for Heart Failure in the REGARDS Study.
Circulation: Heart Failure.
15:12-19.
2022
|
|
| 2021
|
Risk for recurrent cardiovascular disease events among patients with diabetes and chronic kidney disease.
Cardiovascular Diabetology.
20.
2021
|
|
| 2021
|
Million Hearts Cardiac Rehabilitation Think Tank: Accelerating New Care Models.
Circulation: Cardiovascular Quality and Outcomes.
14:e008215.
2021
|
|
| 2021
|
Race/ethnic and sex differences in the initiation of non-statin lipid-lowering medication following myocardial infarction.
Journal of Clinical Lipidology.
15:665-673.
2021
|
|
| 2021
|
Risk Factors for Major Hemorrhage Among Patients Receiving Dabigatran Across the Spectrum of CKD Not Requiring Dialysis Therapy.
American Journal of Kidney Diseases.
78:151-153.
2021
|
|
| 2021
|
Risk for cardiovascular events following microsize' versus usual myocardial infarctions.
Heart.
107:1152-1159.
2021
|
|
| 2021
|
Outcomes of Individuals With and Without Heart Failure Presenting With Acute Coronary Syndrome.
American Journal of Cardiology.
148:1-7.
2021
|
|
| 2021
|
Atrial arrhythmia related outcomes in critically ill COVID-19 patients.
Pacing and Clinical Electrophysiology.
44:814-823.
2021
|
|
| 2021
|
The Dietary Approaches to Stop Hypertension (DASH) Diet Pattern and Incident Heart Failure.
Journal of Cardiac Failure.
27:512-521.
2021
|
|
| 2021
|
Closing Gaps in Lifestyle Adherence for Secondary Prevention of Coronary Heart Disease.
American Journal of Cardiology.
145:1-11.
2021
|
|
| 2021
|
Sex Differences in Factors Contributing to the Racial Disparity in Diabetes Risk.
American Journal of Preventive Medicine.
60:e169-e177.
2021
|
|
| 2021
|
Mediterranean diet score, dietary patterns, and risk of sudden cardiac death in the regards study.
Journal of the American Heart Association.
10.
2021
|
|
| 2020
|
Cardiovascular Disease Events and Mortality After Myocardial Infarction Among Black and White Adults: REGARDS Study.
Circulation: Cardiovascular Quality and Outcomes.
13:E006683.
2020
|
|
| 2020
|
Risk factor control among Black and White adults with diabetes onset in older adulthood: The Reasons for Geographic and Racial Differences in Stroke (REGARDS) study.
Preventive Medicine.
139.
2020
|
|
| 2020
|
Atherosclerotic Risk and Statin Use Among Patients With Peripheral Artery Disease.
Journal of the American College of Cardiology.
76:251-264.
2020
|
|
| 2020
|
Evidence-based beta blocker use associated with lower heart failure readmission and mortality, but not all-cause readmission, among Medicare beneficiaries hospitalized for heart failure with reduced ejection fraction.
PLoS One.
15.
2020
|
|
| 2020
|
Social determinants of health and 90-day mortality after hospitalization for heart failure in the regards study.
Journal of the American Heart Association.
9.
2020
|
|
| 2020
|
Residual risk for coronary heart disease events and mortality despite intensive medical management after myocardial infarction.
Journal of Clinical Lipidology.
14:260-270.
2020
|
|
| 2020
|
The Evolution of the Enzymatic Diagnosis of Myocardial Infarction.
American Journal of the Medical Sciences.
359:67-69.
2020
|
|
| 2019
|
Risk factors for 'microsize' vs. usual myocardial infarctions in the REasons for Geographic and Racial Differences in Stroke (REGARDS) study.
European Heart Journal - Quality of Care and Clinical Outcomes.
5:343-351.
2019
|
|
| 2019
|
Home-Based Cardiac Rehabilitation: A Scientific Statement From the American Association of Cardiovascular and Pulmonary Rehabilitation, the American Heart Association, and the American College of Cardiology.
Journal of Cardiopulmonary Rehabilitation and Prevention.
74:133-153.
2019
|
|
| 2019
|
Home-Based Cardiac Rehabilitation: A Scientific Statement From the American Association of Cardiovascular and Pulmonary Rehabilitation, the American Heart Association, and the American College of Cardiology.
Circulation.
140:E69-E89.
2019
|
|
| 2019
|
Home-based cardiac rehabilitation: A scientific statement from the American association of cardiovascular and pulmonary rehabilitation, the American Heart Association, and the American college of cardiology.
Journal of Cardiopulmonary Rehabilitation and Prevention.
39:208-225.
2019
|
|
| 2019
|
Medication-Taking Behaviors and Perceptions Among Adults With Heart Failure (from the REasons for Geographic And Racial Differences in Stroke Study).
American Journal of Cardiology.
123:1667-1674.
2019
|
|
| 2019
|
Low Utilization of Beta-Blockers Among Medicare Beneficiaries Hospitalized for Heart Failure With Reduced Ejection Fraction.
Journal of Cardiac Failure.
25:343-351.
2019
|
|
| 2019
|
Contemporary Diagnosis and Management of Patients With Myocardial Infarction in the Absence of Obstructive Coronary Artery Disease: A Scientific Statement From the American Heart Association.
Circulation.
139:E891-E908.
2019
|
|
| 2019
|
Characteristics and Cardiovascular Disease Event Rates among African Americans and Whites Who Meet the Further Cardiovascular Outcomes Research with PCSK9 Inhibition in Subjects with Elevated Risk (FOURIER) Trial Inclusion Criteria.
Cardiovascular Drugs and Therapy.
33:189-199.
2019
|
|
| 2019
|
Patterns of Treatment in Patients with Heart Failure with Preserved Ejection Fraction: the REasons for Geographic And Racial Differences in Stroke study
2019
|
|
| 2019
|
PCSK9 loss-of-function variants and Lp(a) phenotypes among black US adults.
Journal of Lipid Research.
60:1946-1952.
2019
|
|
| 2018
|
Differences in Risk of Sudden Cardiac Death Between Blacks and Whites.
Journal of the American College of Cardiology.
72:2431-2439.
2018
|
|
| 2018
|
Titration to High-Intensity Statin Therapy Following Acute Myocardial Infarction in Patients With and Without Diabetes Mellitus.
Cardiovascular Drugs and Therapy.
32:453-461.
2018
|
|
| 2018
|
Dietary patterns and mediterranean diet score and hazard of recurrent coronary heart disease events and all-cause mortality in the regards study.
Journal of the American Heart Association.
7.
2018
|
|
| 2018
|
Healthcare utilization and statin re-initiation among medicare beneficiaries with a history of myocardial infarction.
Journal of the American Heart Association.
7.
2018
|
|
| 2018
|
Causes and temporal patterns of 30-day readmission among older adults hospitalized with heart failure with preserved or reduced ejection fraction.
Journal of the American Heart Association.
7.
2018
|
|
| 2018
|
N-terminal pro-B-type natriuretic peptide and microsize myocardial infarction risk in the reasons for geographic and racial differences in stroke study.
BMC Cardiovascular Disorders.
18.
2018
|
|
| 2017
|
Design and interpretation of non-inferiority studies: A clinician’s perspective.
Journal of Nuclear Cardiology.
24:1994-1997.
2017
|
|
| 2017
|
Statin Discontinuation, Reinitiation, and Persistence Patterns among Medicare Beneficiaries after Myocardial Infarction: A Cohort Study.
Circulation: Cardiovascular Quality and Outcomes.
10.
2017
|
|
| 2017
|
Medical therapy following hospitalization for heart failure with reduced ejection fraction and association with discharge to long-term care: A cross-sectional analysis of the REasons for Geographic And Racial Differences in Stroke (REGARDS) population.
BMC Cardiovascular Disorders.
17.
2017
|
|
| 2017
|
Metabolic syndrome cluster does not provide incremental prognostic information in patients with stable cardiovascular disease: A post hoc analysis of the AIM-HIGH trial.
Journal of Clinical Lipidology.
11:1201-1211.
2017
|
|
| 2017
|
Adherence to high-intensity statins following a myocardial infarction hospitalization among medicare beneficiaries.
JAMA Cardiology.
2:890-895.
2017
|
|
| 2017
|
Trends in Use of High-Intensity Statin Therapy After Myocardial Infarction, 2011 to 2014.
Journal of the American College of Cardiology.
69:2696-2706.
2017
|
|
| 2017
|
Insurance, self-reported medication adherence and LDL cholesterol: The REasons for Geographic And Racial Differences in Stroke study.
International Journal of Cardiology.
236:462-465.
2017
|
|
| 2017
|
Comparison of expert adjudicated coronary heart disease and cardiovascular disease mortality with the National Death Index: Results from the REasons for Geographic And Racial Differences in Stroke (REGARDS) study.
Journal of the American Heart Association.
6.
2017
|
|
| 2017
|
Race-sex differences in statin use and low-density lipoprotein cholesterol control among people with diabetes mellitus in the reasons for geographic and racial differences in stroke study.
Journal of the American Heart Association.
6.
2017
|
|
| 2017
|
Significant Discrepancy Between Estimated and Actual Longevity in St. Jude Medical Implantable Cardioverter-Defibrillators.
Journal of Cardiovascular Electrophysiology.
28:552-558.
2017
|
|
| 2017
|
Albuminuria, kidney function, and sudden cardiac death: Findings from The Reasons for Geographic and Racial Differences in Stroke (REGARDS) study.
Heart Rhythm.
14:65-71.
2017
|
|
| 2017
|
Proprotein convertase subtilisin/kexin 9 (PCSK9) inhibition in patients with or at high risk of coronary heart disease.
US Cardiology Review.
11:16-17.
2017
|
|
| 2017
|
Quality of anticoagulation control and hemorrhage risk among African American and European American warfarin users.
Pharmacogenetics and Genomics.
27:347-355.
2017
|
|
| 2016
|
Diabetes, diabetes severity, and coronary heart disease risk equivalence: REasons for Geographic and Racial Differences in Stroke (REGARDS).
American Heart Journal.
181:43-51.
2016
|
|
| 2016
|
Effect of Left Ventricular Systolic Dysfunction on Response to Warfarin.
American Journal of Cardiology.
118:232-236.
2016
|
|
| 2016
|
Comparison of length of stay, 30-day mortality, and 30-day readmission rates in medicare patients with heart failure and with reduced versus preserved ejection fraction.
American Journal of Cardiology.
118:79-85.
2016
|
|
| 2016
|
Race-Specific Influence of CYP4F2 on Dose and Risk of Hemorrhage among Warfarin Users
2016
|
|
| 2016
|
Response to Letter Regarding Article, "southern Dietary Pattern is Associated with Hazard of Acute Coronary Heart Disease in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study".
Circulation.
133:e416.
2016
|
|
| 2015
|
Power and sample size in clinical studies.
Journal of Nuclear Cardiology.
22:1314-1315.
2015
|
|
| 2015
|
Southern dietary pattern is associated with hazard of acute coronary heart disease in the reasons for geographic and Racial Differences in Stroke (REGARDS) study.
Circulation.
132:804-814.
2015
|
|
| 2015
|
Trends in mortality and recurrent coronary heart disease events after an acute myocardial infarction among Medicare beneficiaries, 2001-2009.
American Heart Journal.
170:249-255.e2.
2015
|
|
| 2015
|
Race influences warfarin dose changes associated with genetic factors.
Blood.
126:539-545.
2015
|
|
| 2015
|
Characteristics and prognosis of acute myocardial infarction by discharge diagnosis: The Reasons for Geographic and Racial Differences in Stroke study.
Annals of Epidemiology.
25:499-504.e1.
2015
|
|
| 2015
|
Race-sex differences in the management of hyperlipidemia: The reasons for geographic and racial differences in stroke study.
American Journal of Preventive Medicine.
48:520-527.
2015
|
|
| 2015
|
Statin use following hospitalization among Medicare beneficiaries with a secondary discharge diagnosis of acute myocardial infarction.
Journal of the American Heart Association.
4.
2015
|
|
| 2015
|
Underutilization of high-intensity statin therapy after hospitalization for coronary heart disease.
Journal of the American College of Cardiology.
65:270-277.
2015
|
|
| 2014
|
Effect of sustaining lifestyle modifications (nonsmoking, weight reduction, physical activity, and Mediterranean diet) after healing of myocardial infarction, percutaneous intervention, or coronary bypass (from the reasons for geographic and racial differences in stroke study).
American Journal of Cardiology.
113:1933-1940.
2014
|
|
| 2014
|
Achievement of optimal medical therapy goals for U.S. adults with coronary artery disease: Results from the REGARDS Study (REasons for Geographic and Racial Differences in Stroke).
Journal of the American College of Cardiology.
63:1626-1633.
2014
|
|
| 2014
|
Claims-based algorithms for identifying Medicare beneficiaries at high estimated risk for coronary heart disease events: A cross-sectional study.
BMC Health Services Research.
14.
2014
|
|
| 2014
|
Aspirin as Primary Prevention of Acute Coronary Heart Disease Events..
British Journal of Medicine and Medical Research.
4:5357-5367.
2014
|
|
| 2014
|
Declines in coronary heart disease incidence and mortality among middle-aged adults with and without diabetes.
Annals of Epidemiology.
24:581-587.
2014
|
|
| 2014
|
Influence of regular physical activity on warfarin dose and risk of hemorrhagic complications
2014
|
|
| 2014
|
Metabolic syndrome, C-reactive protein, and mortality in U.S. blacks and whites: The reasons for geographic and racial differences in Stroke (REGARDS) study.
Diabetes reviews (Alexandria, Va.).
37:2284-2290.
2014
|
|
| 2013
|
Awareness, treatment, and control of LDL cholesterol are lower among U.S. adults with undiagnosed diabetes versus diagnosed diabetes.
Diabetes reviews (Alexandria, Va.).
36:2734-2740.
2013
|
|
| 2013
|
Trends in the prevalence, awareness, treatment and control of high low density lipoprotein-cholesterol among United States adults from 1999-2000 Through 2009-2010.
American Journal of Cardiology.
112:664-670.
2013
|
|
| 2013
|
Cardioprotective medication use and risk factor control among US adults with unrecognized myocardial infarction: The REasons for geographic and racial differences in stroke (REGARDS) study.
Vascular Health and Risk Management.
9:47-55.
2013
|
|
| 2013
|
Hospital laboratory reporting may be a barrier to detection of 'microsize' myocardial infarction in the US: An observational study.
BMC Health Services Research.
13.
2013
|
|
| 2012
|
Awareness and management of chronic disease, insurance status, and health professional shortage areas in the REasons for Geographic and Racial Differences in Stroke (REGARDS): A cross-sectional study.
BMC Health Services Research.
12.
2012
|
|
| 2012
|
Association of race and sex with risk of incident acute coronary heart disease events.
Journal of the American Medical Association.
308:1768-1774.
2012
|
|
| 2012
|
Nonalcoholic Fatty Liver Disease and Cardiovascular Disease Risk.
Clinical Gastroenterology and Hepatology.
10:568-569.
2012
|
|
| 2012
|
Awareness, treatment and control of hypertension, diabetes and hyperlipidemia and area-level mortality regions in the reasons for geographic and racial differences in stroke (REGARDS) study.
Journal of Health Care for the Poor and Underserved.
23:903-921.
2012
|
|
| 2012
|
Epidemiology of obesity, the metabolic syndrome, and chronic kidney disease.
Current Hypertension Reports.
14:152-159.
2012
|
|
| 2012
|
Use of secondary prevention medications among adults with reduced kidney function.
Clinical Journal of the American Society of Nephrology.
7:604-611.
2012
|
|
| 2012
|
The role of cardiac rehabilitation in heart failure patients.
US Cardiology Review.
9:61-65.
2012
|
|
| 2011
|
Association of the metabolic syndrome with atrial fibrillation among United States adults (from the REasons for Geographic and Racial Differences in Stroke [REGARDS] Study).
American Journal of Cardiology.
108:227-232.
2011
|
|
| 2011
|
Heart disease and stroke statistics-2011 update: A report from the American Heart Association.
Circulation.
123.
2011
|
|
| 2011
|
Cardiac rehabilitation outcomes: impact of comorbidities and age..
Journal of Cardiopulmonary Rehabilitation and Prevention.
31:342-348.
2011
|
|
| 2011
|
Clinical research in cardiac rehabilitation and secondary prevention: looking back and moving forward..
Journal of Cardiopulmonary Rehabilitation and Prevention.
31:333-341.
2011
|
|
| 2011
|
Health professional shortage areas, insurance status, and cardiovascular disease prevention in the reasons for geographic and racial differences in stroke (REGARDS) study.
Journal of Health Care for the Poor and Underserved.
22:1179-1189.
2011
|
|
| 2010
|
Exercise as a treatment for the risk of cardiovascular disease.
Current Treatment Options in Cardiovascular Medicine.
12:329-341.
2010
|
|
| 2010
|
Variations in prevalent cardiovascular disease and future risk by metabolic syndrome classification in the REasons for Geographic And Racial Differences in Stroke (REGARDS) study.
American Heart Journal.
159:385-391.
2010
|
|
| 2010
|
Executive summary: Heart disease and stroke statistics-2010 update: A report from the american heart association.
Circulation.
121.
2010
|
|
| 2010
|
Heart disease and stroke statistics - 2010 update: A report from the American heart association.
Circulation.
121:948-954.
2010
|
|
| 2009
|
Biomarkers of atherosclerosis: Clinical applications.
Current Cardiovascular Risk Reports.
3:23-30.
2009
|
|
| 2009
|
Predictors of Cardiac Rehabilitation Referral in Coronary Artery Disease Patients. Findings From the American Heart Association's Get With The Guidelines Program.
Journal of the American College of Cardiology.
54:515-521.
2009
|
|
| 2009
|
Drugs are not enough: The metabolic syndrome - A call for intensive therapeutic lifestyle change.
Journal of the CardioMetabolic Syndrome.
4:20-25.
2009
|
|
| 2009
|
Assessing patient recall of discharge instructions for acute myocardial infarction..
Journal for Healthcare Quality.
31.
2009
|
|
| 2008
|
Biomarkers of atherosclerosis: Clinical applications.
Current Cardiology Reports.
10:497-504.
2008
|
|
| 2008
|
Does prevalence of the metabolic syndrome in women with coronary artery disease differ by the ATP III and IDF criteria?.
Journal of Women's Health.
17:841-847.
2008
|
|
| 2007
|
Management of stable patients with coronary heart disease: Clinical implications of the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial.
Journal of Clinical Lipidology.
1:564-574.
2007
|
|
| 2006
|
B-type natriuretic peptide level in a patient with constrictive pericarditis..
Catheterization and Cardiovascular Interventions.
68:832-834.
2006
|
|
| 2006
|
Quantification of tricuspid regurgitation by live three-dimensional transthoracic echocardiographic measurements of vena contracta area
2006
|
|
| 2005
|
Acute hepatitis E infection in a visitor to Louisiana..
Southern Medical Journal.
98:721-722.
2005
|
|
